News
All News
Press Releases
Product Approvals and Launches
Video
All Video Types
AJMC TV
Guidelines
Insights
OnLocation
Payer Perspectives
Peer Exchange
Post Conference Perspectives
Stakeholder Summit
Podcasts
Conferences
Conference Coverage
Conference Listing
Post Conference Perspectives
Journals
All Journals
The American Journal of Managed Care
Population Health, Equity & Outcomes
Evidence-Based Oncology
About Supplements and Featured Publications
Supplements and Featured Publications Issues
Submit a Manuscript
Events
Institute for Value-Based Medicine
Patient-Centered Oncology Care
Resources
Interactive Tools
Formulary Central
Clinical Spotlight
Microsites
Sponsored Content
CE
About AJMC
AJMC Staff
Anniversary
Seema Sonnad Award
Strategic Alliance Partners
Subscribe
Specialty Area
Biosimilars
Cardiorenalmetabolic
Cardiovascular
Chronic Kidney Disease
Diabetes
Heart Failure
Type 1 Diabetes
Dermatology
Alopecia
Atopic Dermatitis
Psoriasis
Gastroenterology
Hematology
ALL/AML
CLL/SLL
GVHD
Hemophilia
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Non-Hodgkin Lymphoma
Rare Blood
Hepatology
Liver
MASH
Immunology
Allergy
Autoimmune
Inflammation
Lupus
Myasthenia Gravis
Rheumatoid Arthritis
Infectious Disease
COVID-19
HIV
RSV
Vaccines
Mental Health
Major Depressive Disorder
Sleep
Neurology
Duchenne Muscular Dystrophy
Epilepsy
Multiple Sclerosis
Parkinson Disease
Obesity
Oncology
Breast Cancer
Cholangiocarcinoma
Colorectal Cancer
Immuno-Oncology
Liver Cancer
Non–Small Cell Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Small Cell Lung Cancer
Soft Tissue Sarcoma
Ophthalmology
Pulmonology
COPD
Pulmonary Arterial Hypertension
Rare Disease
Spinal Muscular Atrophy
Respiratory
Asthma
Pulmonary Fibrosis
Rheumatology
Women's Health
Topics
Biosimilars
Center on Health Equity & Access
Digital Health
Formulary
Gene Therapy
Guidelines
Health Care Cost
Health Care Delivery
Insurance
Policy
Population Health
Product Approvals and Launches
Technology
Value-Based Care
Spotlight
Free In-Person Regional Events Focused on Oncology and Population Health
Specialty Area
Biosimilars
Cardiorenalmetabolic
Cardiovascular
Chronic Kidney Disease
Diabetes
Heart Failure
Type 1 Diabetes
Dermatology
Alopecia
Atopic Dermatitis
Psoriasis
Gastroenterology
Hematology
ALL/AML
CLL/SLL
GVHD
Hemophilia
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Non-Hodgkin Lymphoma
Rare Blood
Hepatology
Liver
MASH
Immunology
Allergy
Autoimmune
Inflammation
Lupus
Myasthenia Gravis
Rheumatoid Arthritis
Infectious Disease
COVID-19
HIV
RSV
Vaccines
Mental Health
Major Depressive Disorder
Sleep
Neurology
Duchenne Muscular Dystrophy
Epilepsy
Multiple Sclerosis
Parkinson Disease
Obesity
Oncology
Breast Cancer
Cholangiocarcinoma
Colorectal Cancer
Immuno-Oncology
Liver Cancer
Non–Small Cell Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Small Cell Lung Cancer
Soft Tissue Sarcoma
Ophthalmology
Pulmonology
COPD
Pulmonary Arterial Hypertension
Rare Disease
Spinal Muscular Atrophy
Respiratory
Asthma
Pulmonary Fibrosis
Rheumatology
Women's Health
Topics
Biosimilars
Center on Health Equity & Access
Digital Health
Formulary
Gene Therapy
Guidelines
Health Care Cost
Health Care Delivery
Insurance
Policy
Population Health
Product Approvals and Launches
Technology
Value-Based Care
Spotlight
News
Video
Podcasts
Conferences
Journals
Events
Resources
CE
About AJMC
Subscribe
Advertisement
Expanding Horizons: The Present and Future of Bispecific Antibodies Across Oncology
: Episode 1
Opinion
Video
December 23, 2024
Expanding Horizons: The Present and Future of Bispecific Antibodies Across Oncology
Now Viewing
EP: 1.
Expanding Horizons: The Present and Future of Bispecific Antibodies Across Oncology
EP: 2.
Revolutionizing Cancer Treatment: Key Bispecific Antibody Approvals
EP: 3.
How Bispecific Antibodies Are Reshaping Cancer Care
EP: 4.
Optimizing Bispecific Antibody Use: Opportunities to Broaden Patient Access
EP: 5.
Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations
EP: 6.
Overcoming Key Operational Challenges in Integrating Bispecific Therapies
EP: 7.
Partnerships in Bispecific Therapy: A Model for Supporting Community Oncology
EP: 8.
Managing Complexity: Standardizing Workflows for Multiple Bispecific Therapies
EP: 9.
Standardizing CRS Management and Ensuring Smooth Transitions of Care in Bispecific Therapy
EP: 10.
Optimizing Bispecific Antibody Administration With EHR and Technology Solutions
EP: 11.
Addressing Resource and Bandwidth Challenges in Bispecific Antibody Administration
EP: 12.
Payer and Reimbursement Considerations for Bispecific Therapies
EP: 13.
Emerging Therapeutic Areas for Bispecific Antibodies
EP: 14.
Incorporating Bispecific Antibodies Earlier in Treatment and Improving Access in Underserved Communities
EP: 15.
Future Breakthroughs: What’s Next for Bispecific Antibodies in Oncology?
Related Videos
Related Content
Advertisement
September 23rd 2022
A Population Health Approach to Managing Heart Failure
Related Content
Advertisement
September 23rd 2022
A Population Health Approach to Managing Heart Failure
